Search
Lineage Cell Therapeutics Inc
LCTXAdd to Watchlist
1.350USD
+0.045+3.46%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
336.55MMarket Cap
LossP/E TTM
Lineage Cell Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Lineage Cell Therapeutics Inc is 8.00, ranking 181 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.87, which is -11.85% below the recent high of -4.29 and -193.95% above the recent low of -14.30.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.